142.00 -1.00 (-0.70%)
Before hours: 6:17AM EST
Dr. Craig Spencer, Emergency Medicine Physician and Director of Global Health in Emergency Medicine at Columbia University, joined Yahoo Finance to discuss the latest vaccine news and his outlook for the distribution timeline.
Practically everything is going right for Moderna (NASDAQ: MRNA) these days. The biotech announced surprisingly positive efficacy results for its COVID-19 vaccine candidate mRNA-1273, and it has filed for Emergency Use Authorization (EUA) in the U.S. and approval in Europe. Moderna's shares have understandably skyrocketed.
Although these companies saw year-to-date gains ranging between 247% and 700%, billionaire money managers wanted little to do with them in the third quarter.